Bank of America Corp
Change company Symbol lookup
Select an option...
BAC Bank of America Corp
HY Hyster-Yale Materials Handling Inc
CM Canadian Imperial Bank of Commerce
SFRFF Silver Fields Resources Inc
CHKJQ Chesapeake Energy Corp
ESPR Esperion Therapeutics Inc
VEEV Veeva Systems Inc
AVGO Broadcom Inc
IAU iShares Gold Trust

Financials : Banks | Large Cap Value
Company profile

Bank of America Corporation is a bank holding company and a financial holding company. The Company is a financial institution, serving individual consumers and others with a range of banking, investing, asset management and other financial and risk management products and services. The Company, through its banking and various non-bank subsidiaries, throughout the United States and in international markets, provides a range of banking and non-bank financial services and products through four business segments: Consumer Banking, which comprises Deposits and Consumer Lending; Global Wealth & Investment Management, which consists of two primary businesses: Merrill Lynch Global Wealth Management and U.S. Trust, Bank of America Private Wealth Management; Global Banking, which provides a range of lending-related products and services; Global Markets, which offers sales and trading services, and All Other, which consists of equity investments, residual expense allocations and other.

Closing Price
Day's Change
0.60 (2.55%)
B/A Size
Day's High
Day's Low

10-day average volume:

Life Sciences Industry Leader Brian Kim Joins Summit Partners as Executive-in-Residence

10:25 am ET August 5, 2020 (BusinessWire) Print

Global growth equity investor Summit Partners today announced the addition of Brian Kim to the firm's Executive-in-Residence ("EIR") program. In this role, Mr. Kim will work closely with Summit's healthcare & life sciences team to identify new investment opportunities and advise growth stage companies in the life sciences sector.

Mr. Kim joins Summit's EIR program from LGC, an international life sciences tools company. Most recently, Mr. Kim worked at LGC as an Executive Director and President of the Genomics Division, helping lead the company's successful sale to Cinven, Astorg and ADIA in early 2020. Prior to LGC, Mr. Kim was the President of PerkinElmer's Life Science and Tools Division, where he managed a global portfolio of products, including instruments, reagents, software and services. Previously, Mr. Kim held a variety of leadership positions at other global life sciences organizations, including Merck Millipore (a division of Merck) and Life Technologies.

"Brian is an experienced life sciences executive with a passion for driving product innovation and a talent for scaling high-growth businesses," said Ross Stern, a Principal with Summit Partners. "He has substantial experience building and leading companies on a global scale. We are thrilled to bring Brian's perspective to Summit's EIR program."

"Summit has deep experience in and understanding of today's complex healthcare and life sciences landscape," said Mr. Kim. "I am thrilled to work alongside the Summit team in this role and I look forward to leveraging the firm's experience and knowledge to help drive growth in the life sciences industry."

Mr. Kim holds a BA in history from the University of Pennsylvania, a BSE in business and managerial economics from the Wharton School at the University of Pennsylvania and an MBA from the Tuck School of Business at Dartmouth College.

Summit has been active in the healthcare and life sciences sector for more than three decades. Since the firm's founding in 1984, Summit has partnered with more than 100 companies across the healthcare services, healthcare IT and life sciences sectors.

Summit's EIR program is an established element of the firm's growth-oriented investing strategy. Since its inception, the program has facilitated collaboration between seasoned industry executives and Summit's investment teams, working to identify sector-specific opportunities in which EIRs may support companies in an ongoing capacity through board or leadership roles.

About Summit Partners

Founded in 1984, Summit Partners is a global alternative investment firm that is currently managing more than $21 billion in capital dedicated to growth equity, fixed income and public equity opportunities. Summit invests across growth sectors of the economy and has invested in more than 500 companies in technology, healthcare, consumer, financial and business services, and other growth industries. Summit maintains offices in North America and Europe and invests in companies around the world. For more Summit stories and to learn more about #TheSummitPartnersNetwork, visit or follow on LinkedIn.

In the United States of America, Summit Partners operates as an SEC-registered investment advisor. In the United Kingdom, this document is issued by Summit Partners LLP, a firm authorized and regulated by the Financial Conduct Authority. Summit Partners LLP is a limited liability partnership registered in England and Wales with registered number OC388179 and its registered office is at 11-12 Hanover Square, London, W1S 1JJ, UK. This document is intended solely to provide information regarding Summit Partners' potential financing capabilities for prospective portfolio companies.

View source version on

SOURCE: Summit Partners

Meg Devine
+1 617.824.1047
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.